Short Interest in Awakn Life Sciences Corp. (OTCMKTS:AWKNF) Decreases By 98.6%

Awakn Life Sciences Corp. (OTCMKTS:AWKNFGet Free Report) was the recipient of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 100 shares, a decrease of 98.6% from the October 31st total of 7,100 shares. Based on an average daily trading volume, of 44,400 shares, the short-interest ratio is currently 0.0 days.

Awakn Life Sciences Trading Up 15.5 %

Shares of OTCMKTS AWKNF opened at $0.09 on Thursday. The firm’s 50 day moving average price is $0.08 and its 200-day moving average price is $0.09. Awakn Life Sciences has a 52-week low of $0.05 and a 52-week high of $0.19.

Awakn Life Sciences Company Profile

(Get Free Report)

Awakn Life Sciences Corp., a biotechnology company, engages in the researching, developing, operations, and delivering of psychedelic therapeutics to treat addiction and other mental health conditions in the United Kingdom and Europe. The company has a collaboration agreement with the University of Exeter for exploring the use of ketamine-assisted therapy to treat Severe AUD.

Recommended Stories

Receive News & Ratings for Awakn Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Awakn Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.